Vazyme Aims to Ink Strategic Partnership with Nuotai Biology to Bolster Synthetic Biology Collaboration
2 week ago / Read about 0 minute
Author:小编   

Vazyme intends to sign a strategic cooperation agreement with Nuotai Biology, aiming to jointly propel technological advancements and project collaborations in the realm of synthetic biology. Furthermore, the two companies plan to establish a joint venture, with Vazyme holding 49% and Nuotai Biology holding 51% of the shares. Detailed investment amounts and other specifics will be discussed in subsequent negotiations. While this collaboration is anticipated to have a modest impact on Vazyme's 2025 performance, it is important to note that there may be risks and uncertainties associated with future business developments.